Skip to main content

We’re Moving Your Greatest Idea Forward

Have an invention? Tell us about it! Please note that public disclosures such as conference abstracts and publications may preclude our ability to protect your invention. Be sure to inform OTC of any imminent or prior disclosures!

Complete Disclosure Form

Mission

Through our partnerships with faculty, industry, entrepreneurs and investors, ensure that Duke innovations reach the marketplace for the benefit of society and to enable future investment in Duke research and innovation.

Vision

Duke will be a leader in transferring its knowledge and innovations to the worldwide community.

IMPACT: By The Numbers

  • $450M+

    Invested in Duke Start-Ups in FY22

  • 1,300

    Active Invention Disclosures

  • 130

    Current Active Start-Ups

Faculty & Innovators

We work together to augment the impact of your innovations, build connections with industrial, entrepreneurial, legal and investment resources and amplify the value and impact of your Duke innovations.

Learn more about our process

Industry & Partners

Partner with us to bring transformational ideas to the marketplace.

Collaborate with us

New Ventures

Let us help you think through the opportunity, craft a business plan, and connect with the management, mentors, and investors to make your venture a success!

Meet our New ventures Group

Duke Capital Partners

The investment network of Duke alumni, faculty, and parents which provides its members with exciting opportunities to invest in early-stage companies with a Duke connection – and for Duke-affiliated entrepreneurs to pitch their companies for potential investment.

Visit the Duke Capital Partners website

Translational Funds

Learn more about translational funding resources and opportunities that aim to accelerate the path from research to commercialization.

How we support your translational work

Our Technologies

Looking for cutting-edge technology? We welcome you to browse our list of available technologies from therapeutics to imaging and software and find one that will make a difference!

View our Available Technologies

Resources

Bringing your innovation to the market requires a lot of resources. We are here to guide you on available resources at Duke and beyond that will help you realize your dream.

See Available Reources

Duke Start-ups

  • Duke Start-up: Warden Bio

    Warden Bio is developing novel AAV-mediated gene therapies for glycogen storage disorders (GSDs). The GSD gene therapy  is based on research led by the lab of  Dr. Priya Kishnani, Chen Family Distinguished Professor & Division Chief for Medical Genetics at Duke University, in close collaboration with Dr. Aravind Asokan, Professor & Director of Gene Therapy at Duke University and Co-Founder of StrideBio. Over the past three decades, Dr. Kishnani has built an interdisciplinary team with world-leading GSD expertise whose efforts are most notably demonstrated by the long-standing research and clinical experience that resulted in FDA approval of alglucosidase alfa (Myozyme/Lumizyme) as the...

    Founded:

    2021

    Duke Inventors:

    Kishnani Priya, Aravind Asokan, Sun Baodong

    Visit Website for Warden Bio

  • Duke Start-up: Solar Unsoiled

    Solar Unsoiled is an interactive, data-driven platform to optimize global solar energy production. The company is maximizing solar energy profit and reducing financial risk using predictive models to mitigate the impact of energy losses due to dust and air pollution. Solar Unsoiled targets optimization surrounding the issue of detrimental soiling losses.

    Founded:

    2022

    Duke Inventors:

    Michael Valerino

    Visit Website for Solar Unsoiled

  • Duke Start-up: Basking Biosciences Inc.

    Basking Bio, founded by endovascular neurosurgeon and research scientist, Shai Nimjee, is developing a drug-antidote pair for treatment of patients with ischemic stroke using technologies founded out of Duke Professor of Surgery, Bruce Sullenger’s Cardiovascular Biology Lab. Basking Biosciences is developing the only reversible anti-thrombotic therapeutic to treat ischemic stroke. Founded based on IP licensed from Duke and Ohio State Universities, DTRI-031, Basking’s lead compound, leverages the proven aptamer technology platform developed in founder Bruce Sullenger’s lab at Duke to create a highly specific inhibitor of Von Willebrand Factor (VWF) and a paired reversal agent. This paired therapy enables rapid...

    Founded:

    2020

    Duke Inventors:

    Bruce Sullenger , Shai Nimjee

    Visit Website for Basking Biosciences Inc.

See all start-ups

News

see all news

Duke Capital Partners Leads Investment in Reselute

Reselute, founded around Duke technology by a Duke professor and graduates, is developing solutions to orthopedic infections

Read More about Duke Capital Partners Leads Investment in Reselute

Ten63 Therapeutics Raises $15.9 Million in Oversubscribed Series A Financing to Drug the Undruggables by Combining the Power of AI and Physics-based Models

Ten63 is a Duke University start-up founded by Professor Bruce Donald (Computer Science, Trinity), and his students. Ten63 is also a Duke Capital Partners portfolio…

Read More about Ten63 Therapeutics Raises $15.9 Million in Oversubscribed Series A Financing to Drug the Undruggables by Combining the Power of AI and Physics-based Models

Duke Capital Partners Leads Investment in Lacuna Medical

Lacuna Medical is Developing a 3D Shape Catheter that is More Resistant to Failure

Read More about Duke Capital Partners Leads Investment in Lacuna Medical

Events

See all events